Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-45.92	77.24	142.82
Graham Fair Price	115.36	3540.80	1644.17
PEG	-93.93	0.04	-0.64
Price/Book	5.68	1.11	1.05
Price/Cash Flow	inf	0.00	138.68
Prices/Earnings	-72.54	12.61	45.92
Price/Sales	-23.94	1.67	2.20
Price/FCF	inf	0.00	138.68
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-7.29	0.07	0.07
Operating Margin	30.44	0.01	0.01
ROA	244.61	< 0.005	< 0.005
ROE	< 0.005	0.02	284.88
ROIC	< 0.005	< 0.005	90.24
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.25	0.49	-49.54
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.79	0.98	23.75
EPS QOQ	-0.71	3.22	352.05
FCF QOQ	0.08	-1.00	1213.10
Revenue QOQ	< 0.005	0.52	20389.34
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	71.01	39.37	-44.55
Days Sales Outstanding (DSO)	170.66	125.73	-26.33
Inventory Turnover	1.27	2.29	80.35
Debt/Capitalization	0.26	0.29	9.87
Quick Ratio	0.92	1.00	8.54
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	4576.99	5024.25	9.77
Cash	1049.92	2371.57	125.88
Capex	0.00	0.00	0.00
Free Cash Flow	34.77	0.00	inf
Revenue	2193.00	3344.87	52.52
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.29	1.25	-2.61
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	15.35	-4.43	-71.10
Naive Interpretation	Member

06 - Financial Health · Weak

Rating